Company News

Two doctors sitting and looking at an iPad screen together

Press Release

ION Solutions Collaborates with Grifols to Expand Suite of Pharmacy Offerings for Specialty Physician Practices

March 2021

Press Release

ION & IPN Solutions Collaborate with Annexus Health to Offer AssistPoint to Specialty Physician Practices

October 2020

Industry Spotlights

UDENYCA^® (pegfilgrastim-cbqv) Anthem 2021 Payer Coverage Update

March 2021

Ordering ORGOVYX™ (relugolix)

March 2021

Introducing PEPAXTO^® (melphalan flufenamide)

March 2021

XTANDI (enzalutamide) Tablet Formulation Is Available

March 2021

AVASTIN^®, HERCEPTIN^®, and RITUXAN^®: It's likely your patients are covered

March 2021

Introducing COSELA™ (trilaciclib): Now available

March 2021

TAGRISSO^® (osimertinib): The new indication

March 2021

Why is HRD status critical in newly diagnosed advanced ovarian cancer?

February 2021

Help patients with R/R MZL/FL get access to a new treatment

February 2021

New NCCN Category 1 recommendation for CLL

February 2021

Now approved: CABOMETYX^® (cabozantinib) + OPDIVO^® (nivolumab)

February 2021

New indication, now approved: ENHERTU^® (fam-trastuzumab deruxtecan-nxki)

February 2021

Did you know this immunotherapy has 5 lung approvals?

February 2021

Permanent J-Code for fixed-dose HER2+ breast cancer product

February 2021

A new treatment option for resectable NSCLC

February 2021

See a new dosing option for unresectable Stage III NSCLC

January 2021

Stay Up-to-Date With the Latest NCCN Guidelines for AML

January 2021

XPOVIO^® (selinexor): New Indication Now Approved

January 2021